April 30, 2024
1 min read
Save
Sight Sciences awarded $34 million in patent infringement case against Alcon
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Sight Sciences asserted the sale of the Hydrus between Ivantis and Alcon infringed three key patents.
- The jury found that Alcon willfully infringed all three patents.
Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a press release.
The jury found that Alcon willfully infringed three Sight Sciences’ patents, U.S. Patent No. 8,287,482, No. 9,370,443 and No. 11,389,328, with Ivantis’ sale of the Hydrus to Alcon. Sight Sciences was awarded monetary damages of $5.5 million in lost profits and $28.5 million in royalty damages for sales of the Hydrus from its commercial launch through the trial.
The verdict is subject to appeal.
The case was filed in the U.S. District Court for the District of Delaware on Sept. 16, 2021.
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.